Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea
Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea have?
Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea has 86 citations in the OpenAlex counts ScholarIQ stores.
When was Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea published?
Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea has 2019 year in the ScholarIQ index.
What is the open-access status of Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea?
Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea has gold oa status in the ScholarIQ index.
What is the DOI of Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea?
The DOI for Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea is on the source record.
What is the PMID of Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea?
The PMID for Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea is on the source record.
What is the OpenAlex record for Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea?
The OpenAlex for Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea is on the source record.